Injection: Pregnancy: Tranexamic acid crosses the placenta. Clinical experience of use in pregnant women is limited. Usual caution with the use of drugs in pregnancy should be observed.
Lactation: Tranexamic acid passes into breast milk to a concentration of approximately 100 of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.